Cancer Genetics and Nursing Practice: What Every Gastroenterology Nurse Needs to Know

Gastroenterology Nursing

Volumn 23, Issue 1, 2000, Pages 28-39

  Rieger, Paula Trahan ^a   Tinley, Susan T ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLORECTAL TUMOR; EDUCATION; GASTROENTEROLOGY; GENETIC SCREENING; GENETICS; HUMAN; MEDICAL GENETICS; NEEDS ASSESSMENT; NEOPLASM; NURSING; NURSING DISCIPLINE; REVIEW;

COLORECTAL NEOPLASMS; GASTROENTEROLOGY; GENETIC SCREENING; GENETICS, MEDICAL; HUMANS; NEEDS ASSESSMENT; NEOPLASMS; SPECIALTIES, NURSING;

EID: 0033765554     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/00001610-200001000-00006     Document Type: Article

References (72)

1. Aarnio, M., Sankila, R., Pukkala, E., Salovaara-Alatonen, L. A., de la Chapelle, A., Peltomaki, P., Mecklin, J.P., & Jarvinen, H. J. (1999). Cancer risk in mutation carriers of DNA-mismatch repair genes. International Journal of Cancer, 81, 214-218.
2. Ackerman, T. F. (1996). Genetic testing of children for cancer susceptibility. Journal of Pediatric Oncology Nursing, 13, 46-49.
3. American Society of Clinical Oncology. (1996). Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. Journal of Clinical Oncology, 14, 1730-1736.
4. American Society of Human Genetics. (1996). Statement on informed consent for genetic research. American Journal of Human Genetics, 59, 471-474.
5. American Society of Human Genetics & American College of Medical Genetics. (1995). Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Journal of Human Genetics, 57, 1233-1241.
6. American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure. (1998). ASHG statement on professional disclosure of familial genetic information. American Journal of Human Genetics, 62, 474-483.
7. Berk, T., Cohen, Z., Bapat, B., & Gallinger, S. (1999). Negative genetic test result in familial adenomatous polyposis: Clinical screening implications. Diseases of the Colon and Rectum, 42, 307-310.
8. Boardman, L. A., Thibodeau, S. N., Scaid, D. J., Lindor, N. M., McDowell, S. K., Burgart, L. J., Ahlquist, D. A., Podratz, K. C., Pittelkow, M., & Hartmann, L. C. (1998). Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Annals of Internal Medicine, 128, 896-899.
9. Burke, W., Peterson, G., Lynch, P., Botkin, J., Daly, M., Garber, J. E., Kahn, M J., McTiernan, A., Offit, K., Thomson, E., & Varrichio, C. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Journal of the American Medical Association, 277, 915-919.
10. Calzone, K. A. (1996). Where to look for information about cancer genetics and genetic testing. Cancer Practice, 4, 346-349.
11. Cannistra, S. A. (1997). "cancer defeated": Not if, but when-introducing the Biology of Neoplasia series. Journal of Clinical Oncology, 15, 3297-3298.
12. Cavanee, W. K., & White, R. L. (1995). The genetic basis of cancer. Scientific American, 272, 72-79.
13. Collins, F. S. (1999). Shattuck lecture-Medical and societal consequences of the Human Genome Project. New England Journal of Medicine, 341, 28-37.
14. collins, F. S., & Jenkins, J. F. (1997). Implications of the Human Genome Project for the nursing profession. In: F. R. Lashley (Ed.), The genetic revolution: Implications for nursing (pp. 9-13). Washington, DC: American Academy of Nursing.
15. Collins, F. S., Patrino, A., Jordan, E., Chakrvarti, H., Gesteland, R., & Walters, R. (1998). New goals for the Human Genome Project 1998-2003. Science, 282, 682-689.
16. Dimond, E., Calzone, K. A., Davis, J., & Jenkins, J. F. (1998). The role of the nurse in cancer genetics. Cancer Nursing, 21(1), 57-75.
17. Drlica, K. A. (1994). Double-edged sword: The promises and risks of the genetic revolution. Redding, MA: Helix/Addison-Wesley.
18. Ellerhorst-Ryan, J. (1997). The nature of cancer. In: C. Varricchio, M. Pierce, C. L. Walker, & T. B. Ades (Eds.), A cancer source book for nurses (7th ed.). (pp. 27-34). Atlanta, GA: American Cancer Society.
19. Eng, C. (1998). Genetics of Cowden syndrome: Through the looking glass of oncology. International Journal of Oncology, 12(3), 701-710.
20. Fearson, E. R., & Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
21. Frayling, I. M., Beck, N. E., Ilyas, M., Dove-Edwin, I., Goodman, P., Pack, K., Bell, J. A., Williams, C. B., Hodgson, S. V., Thomas, H. J., Talbot, I. C., Bodmer, W. F., & Tomlinson, I. P. (1998). The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proceedings of the National Academy of Sciences United States of America, 95, 10,722-10,727.
22. Garay, C. A., & Engstrom, P. F. (1999). Chemoprevention of colorectal cancer: Dietary and pharmacologic approaches. Oncology, 13(1), 89-105.
23. Garber, J. E., & Schrag, D. (1996). Testing for inherited cancer susceptibility (editorial). Journal of the American Medical Association, 2275, 1928-1929.
24. Giardiello, F. M. (1995). Gastrointestinal polyposis syndromes and hereditary nonpolyposis colorectal cancer. In: A. K. Rustgi (Ed.), Gastrointestinal cancers: Biology, diagnosis and therapy (pp. 367-377). Philadelphia: Lippincott-Raven.
25. Giardiello, F. M., Brensinger, J. P., Peterson, G. M., Luce, M. C., Hylind, L. M., bacon, J. A., Booker, S. V., Parker, R. D., & Hamilton, S. R. (1997). The use and interpretation of commercial APC gene testing for familial adenomatosis polyposis. New England Journal of Medicine, 336, 823-827.
26. Gonick, L., & Wheelis, M. (1991). Cartoon guide to genetics. New York: Harper Perennial.
27. Gould, R. L. (1997). cancer and genetics: Answering your patients' questions: A manual for clinicians and their patients. Huntington, NY:PRR, Inc. and American Cancer Society.
28. Griffoen, G., Bus, P. J., vase, H. F., Verspaget, H. W., & Lamers, C. B. (1997). Extracolonic manifestations of familial adenomatous polyposis: Desmoid tumours and upper gastrointestinal adenomas and carcinomas. Scandinavian Journal of Gastroenterology, 33(225 Suppl.), 85-91.
29. Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L., & Robertson, M. (1991). Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66, 589-600.
30. Healy, B. (1997). BRCA genes-Bookmaking, fortune-telling and medical care. New England Journal of Medicine, 366, 1448-1450.
31. Holtzman, N. A. (1996). Are we ready to screen for inherited susceptibility to cancer? Oncology, 10, 57-64.
32. Howe, J. R., Ringold, J. C., Hughes, J. H., & Summers, R. W. (1999). Direct genetic testing for Smad4 mutations in patients at risk for juvenile polyposis. Surgery, 126(2), 162-170.
33. Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academic Press; 1998.
34. Jacobs, L. A. (1998a). At-risk for cancer: Genetic discrimination in the workplace. Oncology Nursing Forum, 25, 475-480.
35. Jacobs, L. A. (1998b). Hereditary nonpolyposis colon cancer: Genetic basis, testing, and patient-care issues. Oncology Nursing Forum, 25, 719-725.
36. Kinzler, K. W., & Vogelstein, B. (1996). Lessons from hereditary cancer. Cell, 87, 159-170.
37. Kinzler, K. W., Nilbert, M. C., Su, L. K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., & McKechnie, D. (1991). Identification of FAP locus genes from chromosome 5q21. Science, 253(5020), 661-665.
38. Kolesar, J. M. (1998). Pharmacodynamic frontiers: Drug-gene interactions. Highlights in Oncology Practice, 16(1), 12-22.
39. Laken, S. J., Petersen, G. M., Gruber, S. B., Oddoux, C., Ostrer, H., Giardiello, F. M., Hamilton, S. R., Hampel, H., Markowitz, A., Klimstra, D., Jhanwar, S., Winawer, S., Offit, K., Luce, M. C., Kinzler, K. W., & Vogelstein, B. (1997). Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genetics, 17, 79-83.
40. Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1999). Cancer statistics, 1999. CA: A Cancer Journal for Clinicians, 49, 8-31.
41. Lewin, B. (1997). Genes VI. Oxford, England: Oxford University Press.
42. Lin, K. M., Shashidharan, M., Thorson, A. G., Ternent, C. A., Blatchford, G. J., Christensen, M.A., Watson, P., Lemon, S. J., Franklin, B., Karr, B., Lynch, J., & Lynch, H. T. (1998). Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. Journal of Gastrointestinal Surgery, 2, 67-71.
43. Loescher, L. J. (1995). Genetics in cancer prediction, screening, and counseling: Part I. Genetics in cancer prediction and screening. Oncology Nursing Forum, 22(Suppl.), 10-15.
44. Lynch, H. T., Fusaro, R. M., & Lynch, J. F. (1997). Cancer genetics in the new era of molecular biology. Annals of the New York Academy of Sciences, 833, 1-28.
45. Lynch, H. T., & Lynch, P. M. (1999). Invited editorial. Diseases of the Colon and Rectum, 42, 310-312.
46. MacDonald, D. J. (1997). The oncology nurse's role in cancer risk assessment and counseling. Seminars in Oncology Nursing, 13(2), 123-128.
47. Malkin, D., & Knoppers, B. M. (1996). Genetic predisposition to cancer: Issues to consider. Cancer Biology, 7, 49-53.
48. National Advisory Council for Human Genome Research. (1994). Statement on use of DNA testing for presymptomatic identification of cancer risk. Journal of the American Medical Association, 271, 785.
49. National Cancer Institute. (1995). Understanding gene testing. Bethesda, MD: National Institutes of Health. National Cancer Institute. The Nation's investment in cancer research: A budget proposal for fiscal years 1997/1998. (1996). Bethesda, MD: National Institutes of Health, National Cancer Institute.
50. National Human Genome Research Institute. (1995). The Human Genome Project: From maps to medicine. NIH Pub 96-3897. Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.
51. National Center for Human Genome Research. (1996). Review of the ethical, legal, and social implications research program and related activities 1990-1995. Washington, DC: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Center for Human Genome Research.
52. National Comprehensive Cancer Network. (1999). NCCN colorectal cancer screening practice guidelines. Oncology, 13, 152-178.
53. National Society of Genetic Counselors, I. (1997). Predisposition genetic testing for late-onset disorders in adults. Journal of American Medical Association, 278(15), 1217-1220.
54. Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, J., Baba, S., & Hedge, P. (1991). Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science, 253, 665-669.
55. Oncology Nursing Society. (1998). ONS Position Statement: Cancer Genetic Testing and Risk Assessment Counseling. Oncology Nursing Forum, 25, 464.
56. Peltomaki, P., & de la Chapelle, A. (1997). Mutations predisposing to hereditary nonpolyposis colorectal cancer. Advances in Cancer Research, 71, 93-119.
57. Peters, J. A., & Stopfer, J. E. (1996). Role of the genetic counselor in familial cancer risk. Oncology, 10, 159-175.
58. Reuschoff, J., Wallinger, S., Wolfgang, D., Bocker, T., Brockhoff, G., Hofstatder, F., & Fishel, R. (1998). Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proceedings of the National Academy of Sciences United States of America, 95, 11301-11306.
59. Rieger, P. T. (1997a). Emerging strategies in the management of cancer. Oncology Nursing Forum, 24, 728-737.
60. Rieger, P. T. (1997b). The impact of cancer genetics on oncology nursing practice. Nursing Interventions in Oncology, 9, 15-19.
61. Rieger, P. T. (1998). Overview of cancer and genetics: Implications for nurse practitioners. Nurse Practitioner Forum, 9(3), 122-133.
62. Rodriguez-Bigas, M. A., Vasen, H. F., Pekka-Mecklin, J., Myrhoj, T., Jarvinen, H. J., Jass, J. R., Kunitomo, K., Nomizu, T., & Driscoll, D. L. (1997). Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. Annals of Surgery, 225(2), 202-207.
63. Soravia, C., Berk, T., Madlensky, L., Mitri, A., Cheng, H., Gallinger, S., Cohen, Z., & Bapat, B. (1998). Genotype-phenotype correlations in attenuated adenomatous polyposis coli. American Journal of Human Genetics, 62, 1290-1301.
64. Sporn, M. B., Dunlop, N. M., Newton, D. L., Smith, J. M. (1976). Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Federation Proceedings, 35, 1332-1338.
65. Tinley, S. T., & Strauss-Tranin, A. (1999). Cancer genetics and genetic counseling. In: C. Miaskowski & P. Buschel (Eds.). Oncology Nursing Assessment and Clinical Care. St. Louis: Mosby, Inc.
66. Vasen, H. F., van Ballegooijen, M., Buskens, E., Kleibuker, J. K., Tall, B. G., Griffoen, G., Nagengast, F. M., Menko, F. H., & Merra Kahn, P. (1998). A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer, 82, 1632-1637.
67. Vernon, S. W., Gritz, E. R., Peterson, S. K., Amos, C. I., Perz, C. A., Baile, W. F., & Lynch, P. M. (1997). Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychology, 16, 73-86.
68. Wallace, M. H., & Phillips, R. K. (1998). Upper gastrointestinal disease in patients with familial adenomatous polyposis. British Journal of Surgery, 85, 742-750.
69. Watson, P., Lin, K. M., Rodriguez-Bigas, M. A., Smyrk, T., Lemon, S. J., Shashidharan, M., Franklin, B., Karr, B., Thorson, A. G., & Lynch, H.T. (1998). Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer, 83, 259-266.
70. Weber, B. L. (1996). Genetic testing for breast cancer. Science and Medicine, 3, 12-21.
71. Weinberg, R. A. (1996). How cancer arises. Scientific American, 275, 62-70.
72. Winde, G., Schmid, K. W., Burkhardt, M. D., Muller, O., & Osswald, H. (1997). Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis. Diseases of the Colon and Rectum, 40, 1156-1169.